What would you like to look for?
Site search
26 June 2019

VISCHER advises on the capital increase of BACHEM HOLDING AG as transaction counsel. As a result of the capital increase, in which 400'000 new shares were issued, BACHEM (SIX: BANB) received gross proceeds of CHF 48 million, which will be used entirely to finance the growth strategy and further strengthen the balance sheet structure. BACHEM is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. The team at VISCHER is led by Matthias Staehelin with Angelo Imperiale and Sebastian Flückiger (all Corporate).

Press release BACHEM HOLDING AG (DE)